Alkaline phosphatase (ALP) enhancing iridoid glucosides from the Indonesian medicinal plant Barleria lupulina

Natural Product Communications

Volumn 5, Issue 11, 2010, Pages 1711-1716

  Widyowati, Retno ^a   Tezuka, Yasuhiro ^a   Miyahara, Tatsurou ^a   Awale, Suresh ^a   Kadota, Shigetoshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Acanthaceae; Alkaline phosphatase (ALP); Barleria lupulina; Iridoid glucosides; Landik; MC3T3 E1 cells

Indexed keywords

6 O ACETYLSHANZHISIDE METHYL ESTER; 8 O ACETYL 6 O (4 METHOXY CINNAMOYL)SHANZHISIDE; 8 O ACETYL 6 O (4 METHOXYTRANSCINNAMOYL)SHANZHISIDE; 8 O ACETYL 6 O 4 COUMAROYLSHANZHISIDE METHYL ESTER; 8 O ACETYLIPOLAMIIDIC ACID; 8 O ACETYLSHANZHISIDE; ACETYLBARLERIN; ALKALINE PHOSPHATASE; BARLERIN; IPOLAMIID; IPOLAMIIDOSIDE; IRIDOID; PROSTAGLANDIN E2; SHANZHISIDE; SHANZHISIDE METHYL ESTER; UNCLASSIFIED DRUG;

ARTICLE; BARLERIA LUPULINA; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; ENZYME ACTIVITY; INDONESIA; MEDICINAL PLANT; OSTEOBLAST; PHYTOCHEMISTRY;

ACANTHACEAE; BARLERIA LUPULINA;

EID: 78751653635     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1000501101     Document Type: Article

References (33)

1. Holroyd C, Cooper C, Dennison E. (2008) Epidemiology of osteoporosis. Best Practice & Research. Clinical Endocrinology & Metabolism, 22, 671-685.
2. Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. (2003) Bisphosphonate-induced osteopetrosis. New England Journal of Medicine, 349, 457-463.
3. Girotra M, Rubin MR, Bilezikian JP. (2006) The use of parathyroid hormone in the treatment of osteoporosis. Reviews in Endocrine & Metabolic Disorders, 7, 113-121. (Pubitemid 46049523)
4. Dawney PA, Siegel M. (2006) Bone biology and the clinical implications for osteoporosis. Physical Therapy, 86, 77-91. (Pubitemid 43031268)
5. Li J-X, Hareyama T, Tezuka Y, Zhang Y, Miyahara T, Kadota S. (2005) Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity of osteoclast formation. Planta Medica, 71, 673-679. (Pubitemid 41133079)
6. Li H, Li J, Prasain JK, Tezuka Y, Namba T, Miyahara T, Tonami S, Seto H, Tada T, Kadota S. (1998) Antiosteoporotic activity of the stems of Sambucus sieboldiana. Biological & Pharmaceutical Bulletin, 21, 594-598. (Pubitemid 28317315)
7. Li H, Miyahara T, Tezuka Y, Namba T, Nemoto N, Tonami S, Seto H, Tada T, Kadota S. (1998) The effect of kampo formulae on bone resorption in vitro and in vivo. I. Active constituents of Tsu-kan-gan. Biological & Pharmaceutical Bulletin, 21, 1322-1326.
8. Shi L, Tezuka Y, Miyahara T, Yin J, Nobukawa T, Kadota S. (2007) Inhibitory effect of constituents of Bu-Shen-Jian-Gu-Tang on osteoclast-like cell formation. Journal of Traditional Medicine, 24, 19-23.
9. Yin J, Tezuka Y, Kouda K, Tran QL, Miyahara T, Chen Y, Kadota S. (2004) In vivo antiosteoporotic activity of a fraction of Dioscorea spongiosa and its constituent, 22-O-methylprotodioscin. Planta Medica, 70, 220-226.
10. Torii Y, Hitomi K, Yamagishi Y. Tsukagoshi N. (1996) Demonstration of alkaline phosphatase participation in the mineralization of osteoblasts by antisense RNA approach. Cell Biology International, 20, 459-464. (Pubitemid 26379884)
11. PT Eisai Indonesia (1995) Medicinal Herb Index in Indonesia. PT Eisai Indonesia, Jakarta, pp. 247-248.
12. Chopra RN, Nayar SL, Chopra IC. (1968) Glossary of Indian Medicinal Plants (Suppl.). Academic Publishers, New Delhi, India, p. 20.
13. Suba V, Murugesan T, Kumaravelrajan R, Mandal SC, Saha BP. (2005) Antiinflammatory, analgesic and antiperoxidative efficacy of Barleria lupulina Lindl. extract. Phytotherapy Research, 19, 695-699. (Pubitemid 41433634)
14. Suba V, Murugesan T, Rao RB, Ghosh L, Pal M, Mandal SC, Saha BP. (2004) Antidiabetic potential of Barleria lupulina extract in rats. Fitoterapia, 75, 1-4. (Pubitemid 38010396)
15. Suba V, Murugesan T, Rao RB, Pal M, Mandal SC, Saha BP. (2002) Neuropharmacological profile of Barleria lupulina Lindl. extract in animal models. Journal of Ethnopharmacology, 81, 251-255. (Pubitemid 34628510)
16. Chomnawang MT, Surassmo S, Nukoolkarn VS, Gritsanapan W. (2005) Antimicrobial effects of Thai medicinal plants against acne-inducing bacteria. Journal of Ethnopharmacology, 101, 330-333. (Pubitemid 41265642)
17. Suba V, Murugesan T, Pal M, Mandal SC, Saha BP. (2004) Antiulcer activity of methanol fraction of Barleria lupulina Lindl. in animal models. Phytotherapy Research, 18, 925-929. (Pubitemid 40052772)
18. Yoosook C, Panpisutchai Y, Chaichana S, Santisuk T, Reutrakul V. (1999) Evaluation of anti-HSV-2 activities of Barleria lupulina and Clinacanthus nutans. Journal of Ethnopharmacology, 67, 179-187. (Pubitemid 29421673)
19. Byrne LT, Sasse JM, Skelton BW, Suksamrarn A, White AH. (1987) The minor iridoid glucosides of Barleria lupulina: isolation, crystal structure and plant growth-inhibiting properties of 6-O-acetylshanzhiside methyl ester. Australian Journal of Chemistry, 40, 785-794.
20. Kanchanapoom T, Kasai R, Yamasaki K. (2001) Iridoid glucosides from Barleria lupulina. Phytochemistry, 58, 337-341.
21. Suksamrarn A. (1986) Iridoid glucosides from Barleria lupulina. Journal of Natural Products, 49, 179.
22. Tuntiwachwuttikul P, Pancharoen O, Taylor WC. (1998) Iridoid glucosides of Barleria lupulina. Phytochemistry, 49, 163-166.
23. Güvenalp Z, Özbek H, Ünsalar T, Kazaz C, Demirezer LÖ. (2006) Iridoid, flavonoid and phenylethanoid glycosides from Wiedemannia orientalis. Turkish Journal of Chemistry, 30, 391-400.
24. Tantisewie B, Sticher O. (1975) Isolation of ipolamiide from Stachytarpheta indica. Phytochemistry, 14, 1462-1463.
25. Bianco A, Guiso M, Iavarone C, Martini-Bettolo R, Trogolo C. (1976) Iridoids. XXI. The stereochemistry of ipolamiide and the structure of its natural 8-O-acetyl derivative, ipolamiidoside. Gazzetta Chimica Italiana, 106, 947-953.
26. Çalis I, Güvenç A, Armagan M, Koyuncu M, Gotfredsen CH, Jensen SR. (2008) Secondary metabolites from Eremostachys laciniata. Natural Product Communications, 3, 117-124.
27. Inouye H, Saito S, Shingu T. (1970) Ein weiteres iridoidglucosid aus Gardenia jasminoides: shanzhisid. Tetrahedron Letters, 11, 3581-3584.
28. Bianco A, Francesconi A, Passacantilli P. (1981) Iridoid glucosides of Odontites verna. Phytochemistry, 20, 1421-1422.
29. Ersöz T, Ivancheva S, Akbay P, Sticher O, Çalis I. (2001) Iridoid and phenylethanoid glycosides from Phlomis tuberosa L. Zeitschrift für Naturforschung, 56C, 695-698.
30. Damtoft S, Jensen SR, Nielsen BJ. (1982) Structural revision of barlerin and acetyl barlerin. Tetrahedron Letters, 23, 4155-4156.
31. Chen JL, Blanc P, Stoddart CA, Bogan M, Rozhon EJ, Parkinson N, Ye Z, Cooper R, Balick M, Nanakorn W, Kernan MR. (1998) New iridoids from the medicinal plant Barleria prionitis with potent activity against respiratory syncytial virus. Journal of Natural Products, 61, 1295-1297. (Pubitemid 28513364)
32. Benvenuti S, Tanini A, Frediani U, Bianchi S, Masi L, Casano R, Bufalino L, Serio M, Brandi ML. (1991) Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. Journal of Bone Mineral Research, 6, 987-996.
33. 2, parathyroid hormone, 1,25 dihydroxycholecalciferol, and cyclic nucleotide analogs on alkaline phosphatase activity in osteoblastic cells. Calcified Tissue International, 36, 72-76.